Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)

Funding Agency:
National Institutes of Health

This Funding Opportunity Announcement (FOA) invites applications that propose to develop novel research infrastructure that will advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations.

This FOA utilizes NIH’s R61/R33 Exploratory/Developmental Phased Award activity code. The R61 phase provides up to 2 years of support for initial developmental activities. The R33 phase provides up to 3 years of support for expanded activities.

Through this award, investigators will endeavor to develop a sustainable research infrastructure to support projects that address key interdisciplinary aging research questions.

Companion FOA: PAR-23-054 , R33 Exploratory/Developmental Grants Phase II

Application Dates: July 3, 2023; Nov 2, 2023; June 3, 2024; Oct. 4, 2024; June 2, 2025; Oct. 3 3, 2025

PAR-23-053 Expiration Date New Date November 04, 2025 (Original Date: December 03, 2025) per issuance of NOT-AG-23-071

Agency Website

Amount Description

Annual direct costs (excluding consortium facilities and administration costs) must remain under $500,000 in both R61 and R33 phases.

    Funding Type

    Grant

    Eligibility

    Faculty

    Category

    Interdisciplinary
    Medical
    Medical - Basic Science
    Medical - Clinical Science
    Medical - Translational
    Social Sciences

    External Deadline

    June 3, 2024